Current LLMs are intelligent enough for many tasks but fail because they lack access to complete context—emails, Slack messages, past data. The next step is building products that ingest this real-world context, making it available for the model to act upon.

Beyond early discovery, LLMs deliver significant value in clinical trials. They accelerate timelines by automating months of post-trial documentation work. More strategically, they can improve trial success rates by analyzing genomic data to identify patient populations with a higher likelihood of responding to a treatment.

Leading LLMs can now replicate a two-hour human software engineering task with 50% accuracy. This capability is doubling every seven months, signaling an urgent need for organizations to adapt their data infrastructure, security, and governance to leverage this exponential growth.

GTM leaders no longer need to delegate strategy implementation. With tools like ChatGPT, their spoken words can become code, allowing them to rapidly prototype and test complex, data-driven prospecting campaigns themselves, directly connecting high-level strategy to on-the-ground execution.

AI agents can continuously experiment with variables like subject lines, send times, and offers for each individual user. This level of granular, ongoing A/B testing is impossible to manage manually, unlocking significant performance lifts that compound over time.

The evolution of AI in go-to-market moves beyond basic content generation (AI 1.0) to automating tedious coordination tasks like pulling lists and updating fields (AI 1.5). This frees human teams from low-leverage work to focus on high-level strategy and creative execution.

Contrary to the hype around real-time AI, the most practical emerging enterprise LLM use case is batch inference. This approach allows for generating assets on a schedule, followed by human review and approval, providing a crucial safety layer before deploying AI into production systems.

IBM's CEO explains that previous deep learning models were "bespoke and fragile," requiring massive, costly human labeling for single tasks. LLMs are an industrial-scale unlock because they eliminate this labeling step, making them vastly faster and cheaper to tune and deploy across many tasks.

YipitData had data on millions of companies but could only afford to process it for a few hundred public tickers due to high manual cleaning costs. AI and LLMs have now made it economically viable to tag and structure this messy, long-tail data at scale, creating massive new product opportunities.